achiev
success
infect
envelop
virus
need
fuse
host
cell
membran
deliv
viral
genom
host
cell
virus
herp
simplex
viru
sendai
viru
human
immunodefici
viru
appear
capabl
direct
fusion
plasma
membran
initi
attach
howev
major
envelop
virus
use
endocytosi
uptak
transport
prior
fusion
sinc
endocyt
cargo
may
eventu
end
destruct
environ
lysosom
environment
cue
crucial
trigger
viral
fusion
right
stage
traffick
trigger
may
includ
decreas
ph
chang
redox
environ
proteolyt
activ
induc
conform
chang
viral
fusion
protein
lead
merger
viral
host
membran
two
wellstudi
virus
influenza
viru
iav
vesicular
stomat
viru
vsv
known
undergo
fusion
upon
exposur
low
ph
envelop
virus
respiratori
syncyti
viru
rsv
ebola
viru
requir
proteolyt
process
viral
fusion
protein
endosom
system
fusion
occur
coronavirus
cov
envelop
plusstrand
rna
virus
belong
famili
coronavirida
order
nidoviral
capabl
infect
wide
varieti
mammalian
avian
speci
case
caus
respiratori
andor
intestin
tract
diseas
human
coronavirus
hcov
known
major
caus
common
cold
eg
howev
emerg
new
hcov
zoonot
origin
shown
potenti
cov
caus
lifethreaten
diseas
human
demonstr
sarscov
epidem
recent
merscov
middl
east
wellstudi
mous
hepat
viru
mhv
often
use
safe
model
studi
cov
infect
cov
virion
contain
canon
set
four
structur
protein
viral
genom
rna
encapsid
nucleocapsid
protein
n
form
helic
nucleocapsid
surround
lipoprotein
envelop
contain
membran
glycoprotein
small
envelop
protein
e
well
spike
glycoprotein
review
trimer
cov
protein
type
membran
protein
belong
class
fusion
protein
form
peplom
protrud
virion
surfac
protein
divid
two
function
subunit
aminotermin
subunit
contain
receptorbind
domain
carboxytermin
subunit
contain
domain
requir
fusion
includ
fusion
peptid
fp
heptad
repeat
domain
hr
transmembran
tm
domain
variou
entri
rout
describ
use
differ
cov
infect
cell
clathrindepend
well
clathrin
caveolaeindepend
entri
pathway
report
sarscov
also
felin
infecti
periton
viru
fipv
suggest
enter
via
clathrin
caveolaeindepend
endocyt
rout
caveolaedepend
endocyt
uptak
suggest
although
abil
mhv
protein
caus
cellcel
fusion
neutral
ph
initi
interpret
indic
fusion
virion
cell
surfac
recent
studi
indic
requir
clathrinmedi
endocytosi
entri
mhv
howev
studi
report
mhv
strain
sensit
lysosomotrop
agent
affect
endocytosi
case
accord
other
proteolyt
cleavag
cov
protein
appear
import
induct
cellcel
fusion
andor
viru
entri
host
cell
differ
cleavag
site
identifi
differ
cov
import
seem
differ
cellcel
viruscel
fusion
cov
protein
includ
mhv
strain
cleav
boundari
furin
like
proteas
transport
newli
assembl
virion
secretori
pathway
produc
cell
inhibit
protein
cleavag
shown
inhibit
cellcel
fusion
affect
entri
mhv
strain
host
cell
mhv
strain
contain
protein
cleav
boundari
interestingli
although
mhv
strain
report
enter
via
clathrinmedi
endocytosi
entri
mhv
mhv
block
inhibitor
lowph
activ
cathepsin
proteas
inhibitor
cathepsin
proteas
also
shown
inhibit
entri
sarscov
felin
cov
treatment
cellbound
viru
particl
differ
proteas
shown
enhanc
viru
entri
andor
cellcel
fusion
sarscov
infecti
bronchiti
viru
ibv
appear
proteolyt
cleavag
protein
downstream
posit
boundari
upon
receptor
bind
import
cell
entri
present
studi
perform
detail
investig
entri
differ
cov
use
sirna
gene
silenc
found
prototyp
coronaviru
mhv
strain
refer
mhv
requir
protein
known
import
late
endosom
matur
endosomelysosom
fusion
effici
infect
cell
use
recombin
mhv
express
report
gene
well
appli
novel
replicationindepend
fusion
assay
confirm
import
clathrinmedi
endocytosi
demonstr
traffick
mhv
virion
lysosom
compart
process
protein
lysosom
proteas
requir
product
entri
occur
result
indic
cleavag
site
protein
cov
immedi
upstream
fp
determin
site
fusion
agreement
herewith
fipv
requir
process
lysosom
proteas
also
shown
depend
traffick
lysosom
contrast
merscov
contain
minim
furincleavag
site
consensu
sequenc
protein
immedi
upstream
fp
neg
affect
inhibit
furin
lysosom
proteas
autom
highthroughput
rnai
screen
target
druggabl
genom
approxim
gene
number
protein
associ
endocytosi
found
requir
effici
infect
hela
cell
gfpexpress
mhv
valid
find
protein
subject
followup
analysi
use
sirnamedi
gene
silenc
oligonucleotid
differ
supplier
one
use
initi
rnai
screen
fig
followup
analysi
includ
two
major
constitu
complex
import
format
actin
branch
cell
surfac
protrus
well
motil
sever
pathogen
insid
host
cell
review
also
select
rasrel
gtpbind
protein
famili
member
shown
involv
endosom
matur
review
interact
amongst
other
member
homotyp
fusion
vacuol
protein
sort
hop
tether
complex
involv
late
endosom
lysosom
matur
hop
subunit
review
also
found
strong
hit
sirna
screen
therefor
select
protein
includ
involv
retrograd
transport
cargo
endosom
transgolgi
network
review
vcl
inter
alia
involv
connect
complex
integrin
actin
polymer
review
serthrprotein
kinas
activ
famili
implic
varieti
downstream
effect
includ
modul
actin
cytoskeleton
review
transfect
hela
cell
carri
receptor
mhv
cell
differ
sirna
follow
infect
gfpexpress
mhv
mhvegfpm
low
multipl
infect
moi
result
approxim
infect
cell
control
condit
h
infect
cell
collect
gfp
express
replic
mhv
analyz
fluorescenceactiv
cell
sort
fac
control
sirna
silenc
gfp
negativecontrol
sirna
use
hit
screen
consid
confirm
transfect
least
two
three
independ
sirna
result
signific
reduct
mhvdriven
gfp
express
rel
negativecontrol
sirna
sirnamedi
gene
silenc
result
reduc
infect
three
sirna
indic
actin
branch
import
mhv
infect
figur
dark
orang
also
import
protein
involv
lateendosom
lateendosom
lysosom
matur
mhv
infect
could
confirm
figur
turquois
light
green
import
vcl
infect
hela
cell
mhv
could
confirm
figur
grey
latter
three
gene
studi
valid
transfect
protocol
confirm
efficaci
sirna
mrna
level
quantit
rtpcr
analysi
perform
sirna
use
reduc
correspond
mrna
level
figur
sirna
target
shown
inhibit
express
protein
figur
text
confirm
extend
understand
role
endocytosi
mhv
entri
subsequ
select
number
protein
known
involv
either
caveola
clathrinmedi
endocytosi
actin
microtubulemedi
transport
well
protein
associ
endosom
vesicl
endosom
matur
screen
use
sirna
silencingapproach
describ
protein
consid
import
infect
mhv
transfect
least
two
three
independ
sirna
result
signific
reduct
mhvdriven
gfp
express
rel
negativecontrol
sirna
sirnamedi
downregul
protein
involv
caveolaemedi
endocytosi
reveal
protein
analyz
import
infect
mhv
figur
light
blue
downregul
protein
associ
clathrinmedi
endocytosi
inhibit
mhv
infect
includ
cltc
sirnamedi
silenc
accessori
factor
clathrinmedi
endocytosi
affect
mhv
replic
figur
dark
blue
silenc
earli
endosomeassoci
gene
figur
cerulean
decreas
replicationmedi
gfp
express
downregul
involv
actinbas
motil
influenc
mhv
infect
figur
dark
orang
result
indic
microtubuleassoci
motil
protein
import
infect
mhv
figur
orang
silenc
nsf
requir
transport
earli
late
endosom
hop
subunit
involv
late
endosom
lysosom
matur
review
result
sever
reduc
mhv
infect
figur
turquois
light
green
respect
explor
endocyt
rout
factor
involv
mhv
infect
determin
effect
inhibitor
mhv
infect
cell
treat
endocytosisaffect
agent
min
infect
luciferaseexpress
mhv
mhveflm
presenc
inhibitor
inhibitor
kept
present
cell
lysi
cell
inocul
mhveflm
absenc
inhibitor
inhibitor
ad
cell
h
post
infect
hpi
assess
effect
inhibitor
postentri
step
hpi
cell
lyse
firefli
luciferas
express
level
determin
infect
presenc
solvent
dimethyl
sulfoxid
dmso
methanol
meoh
well
known
inhibitor
mhv
rna
synthesi
brefeldin
brefa
inhibitor
proteasom
inhibitor
probabl
also
affect
mhv
entri
includ
control
mhv
infect
affect
addit
solvent
wherea
brefa
sever
decreas
luciferas
express
regardless
time
addit
inhibit
endosom
matur
ammonium
chlorid
bafilomycin
chloroquin
chloq
sever
diminish
luciferas
express
inhibitor
ad
prior
infect
much
smaller
effect
observ
drug
ad
hpi
indic
inhibitor
mainli
affect
mhv
entri
figur
deep
sky
blue
similar
effect
observ
known
inhibitor
clathrinmedi
endocytosi
chlorpromazin
chlopro
monensin
mon
dynasor
dyngo
compound
strongli
decreas
mhv
replicationmedi
luciferas
express
ad
earli
ad
hpi
figur
dark
blue
actin
macropinocytosisaffect
drug
eipa
inhibit
nah
exchang
led
reduc
luciferas
express
ad
prior
entri
mhv
hpi
actin
cytoskeleton
alter
drug
latrunculin
lata
jasplakinolid
jasp
cytochalasin
b
cytob
cytochalasin
cytod
induc
microtubul
depolymer
nocodazol
noc
decreas
mhv
infect
ad
earli
indic
role
actin
microtubul
cytoskeleton
entri
rna
replic
figur
dark
orang
orang
likewis
cholesterol
transportaffect
agent
also
prevent
matur
late
endosom
strong
inhibitori
effect
mhv
infect
ad
earli
figur
turquois
collect
result
indic
import
role
clathrinmedi
uptak
endosom
endosometolysosom
matur
mhv
infect
timeofaddit
experi
differ
inhibitor
indic
particularli
entri
step
mhv
infect
cycl
neg
affect
perturb
clathrinmedi
endocytosi
endosom
matur
howev
assay
base
report
gene
express
driven
viru
replic
allow
discrimin
viru
entri
rna
replic
analyz
sirna
agent
also
affect
rna
synthesi
unequivoc
demonstr
import
clathrinmedi
endocytosi
endosom
matur
mhv
entri
therefor
made
use
fusion
assay
recent
develop
assay
base
minim
complement
defect
short
recombin
mhv
contain
n
protein
tag
use
infect
express
target
cell
upon
fusion
virion
host
cell
membran
releas
cytoplasm
result
complement
defect
therebi
reconstitut
function
enzym
convers
nonfluoresc
substrat
fdg
green
fluorophor
fluorescein
fic
measur
fac
fluoresc
microscopi
figur
text
analyz
effect
rnaimedi
gene
silenc
fusion
hela
cell
express
mhv
receptor
cell
transfect
individu
sirna
inocul
h
post
transfect
infect
cell
preload
fdg
hypoton
shock
min
incub
cell
viru
cell
collect
amount
fic
gener
result
enzym
complement
analyz
fac
fusion
assay
show
silenc
neither
affect
mhv
fusion
figur
light
blue
even
though
reduct
shown
affect
mhv
infect
figur
howev
downregul
clathrinmedi
endocytosi
associ
protein
cltc
lead
strongli
decreas
fusion
lack
earli
endosomeassoci
factor
figur
dark
blue
cerulean
respect
fusion
also
affect
rnaimedi
reduct
actin
cytoskeletonassoci
protein
figur
dark
orang
protein
known
involv
late
endosom
late
endosometolysosom
matur
figur
turquois
light
green
import
clathrinmedi
endocytosi
endosom
matur
mhv
fusion
confirm
analysi
endocytosisaffect
agent
use
fusion
assay
preload
fdg
cell
pretreat
inhibitor
min
cell
inocul
presenc
agent
analyz
fac
describ
control
includ
protein
synthesi
inhibitor
cycloheximid
chx
mhv
fusion
inhibitor
peptid
brefa
fusion
mhv
affect
solvent
chx
latter
confirm
assay
independ
rna
replic
protein
synthesi
mhv
fusion
bare
affect
replic
inhibitor
brefa
wherea
clear
neg
effect
agreement
conclus
drawn
previous
inhibit
entri
mhv
well
rna
synthesi
inhibit
endosom
matur
chloq
figur
deep
sky
blue
clathrinmedi
endocytosi
chlopro
mon
dynasor
figur
dark
blue
sever
inhibit
mhv
fusion
disturb
actin
cytoskeleton
eipa
lata
cytob
cytod
reduc
fusion
figur
dark
orang
interfer
microtubul
polymer
noc
smaller
effect
figur
orang
late
endosom
matur
arrest
caus
reduc
fusion
approxim
figur
turquois
conclus
replicationindepend
fusion
assay
confirm
import
clathrinmedi
endocytosi
endosom
matur
entri
mhv
data
indic
late
endosometolysosom
matur
requir
effici
entri
fusion
confirm
import
endocyt
uptak
associ
mhv
endosom
compart
perform
livecel
confoc
microscopi
end
sucros
densiti
gradientpurifi
mhv
viru
coval
label
lowph
resist
dye
dylight
cell
transfect
plasmid
express
monomer
rfp
mrfp
fusion
protein
h
post
transfect
bound
cell
min
inocul
medium
replac
warm
medium
contain
trypan
blue
immedi
shift
emiss
spectrum
surfac
bound
particl
render
undetect
nm
channel
unless
get
endocytos
cell
imag
use
spinningdisc
confoc
microscop
acquir
zstack
interv
min
time
frame
min
post
warm
lowlevel
rfp
fusion
protein
express
cell
select
analysi
interestingli
mhv
particl
newli
appear
even
min
post
warm
agreement
notion
mhv
enter
unsynchron
manner
unpublish
result
coloc
cotraffick
virus
endosom
compart
assess
detect
viru
particl
base
size
intens
green
channel
measur
underli
intens
red
channel
endosom
vesicl
mhv
virion
found
coloc
three
endosom
compart
fig
wherea
newli
enteringappear
particl
alway
coloc
molecul
associ
contain
vesicl
later
time
point
assess
associ
mhv
endosom
vesicl
entri
process
extens
manual
track
viru
particl
green
channel
independ
track
endosom
vesicl
red
channel
xy
zdirect
virion
categor
associ
certain
endosom
marker
coloc
observ
least
four
sequenti
interv
imag
initi
coloc
lost
virion
disappear
virion
classifi
associatingdissoci
complet
disappear
viru
particl
includ
zstack
immedi
previous
coloc
endosom
marker
categor
fusion
event
figur
text
viral
particl
coloc
endosom
compart
neither
dissoci
fade
min
acquisit
period
classifi
nonfus
quantif
method
analyz
virion
total
endosom
compart
type
studi
fraction
virion
fuse
acquisit
period
consist
found
around
observ
enter
mhv
particl
initi
coloc
earli
endosom
vesicl
virion
dissoci
longer
coloc
min
notabl
appear
event
marker
fade
rather
move
away
small
percentag
virion
categor
fuse
earli
endosom
number
fusion
event
much
higher
virion
coloc
figur
indic
virion
fuse
late
endosom
lysosom
result
far
indic
virion
enter
cell
access
late
endosomeslysosom
hypothes
compart
provid
environment
cue
requir
product
viruscel
fusion
order
analyz
extent
low
ph
endosom
system
requir
entri
mhv
analyz
inhibit
mhv
entri
differ
concentr
high
concentr
use
result
shown
fig
affect
endosom
matur
low
concentr
inhibitor
vacuolartyp
hatpas
elev
ph
endosom
compart
affect
endosom
traffick
per
se
made
use
properti
test
sensit
mhv
side
side
control
virus
vsv
iav
vsv
describ
fuse
ph
earli
andor
late
endosom
iav
shown
fuse
late
endosom
even
lower
ph
hela
cell
pretreat
increas
concentr
min
prior
infect
report
gene
express
virus
vsv
iav
iavrluc
mhv
mhveflm
luciferas
express
level
indic
infect
cell
vsv
iav
much
affect
valu
nm
respect
compar
mhv
display
three
four
fold
higher
nm
figur
result
thu
indic
mhv
much
less
affect
perturb
endosom
ph
vsv
iav
nevertheless
rnaimedi
silenc
hop
subunit
treatment
cell
indic
late
endosometolysosom
matur
requir
effici
entri
confirm
extend
observ
made
use
haploid
cell
lack
function
hop
complex
result
lentiviralmedi
knockout
subunit
cell
cell
cell
modifi
stabli
express
mhv
receptor
control
cell
addit
stabli
transfect
flagtag
differ
cell
express
similar
level
mhv
receptor
determin
fac
analysi
figur
text
express
confirm
western
blot
figur
text
function
reconstitut
confirm
confoc
fluoresc
imag
lysosom
local
figur
text
knockout
cell
lysosom
cluster
lysosom
dispers
throughout
cytoplasm
retransfect
cell
observ
parent
cell
haploid
cell
infect
luciferas
report
geneexpress
mhv
vsv
iav
low
moi
cell
lyse
mhv
vsv
iav
hpi
luciferas
express
level
determin
lack
function
hop
complex
effect
vsv
iav
infect
howev
mhv
infect
strongli
reduc
knockout
retransfect
cell
figur
observ
confirm
conclus
late
endosometolysosom
matur
requir
effici
entri
mhv
characterist
share
phsensit
vsv
iav
consid
mhv
much
less
affect
perturb
endosom
ph
iav
vsv
requir
traffick
lysosom
effici
entri
hypothes
entri
might
depend
cleavag
viral
protein
lysosom
proteas
henc
analyz
extent
differ
proteas
inhibitor
could
inhibit
mhv
entri
thu
cell
pretreat
min
differ
inhibitor
cell
inocul
inhibitorcontain
medium
cell
collect
load
fdg
fdg
convers
fic
complement
upon
viral
fusion
assess
fac
result
indic
proteas
inhibitor
test
fig
hardli
inhibit
fusion
mhv
except
aebsf
shown
caus
aggreg
earli
endosom
vesicl
panlysosom
proteas
inhibitor
cpi
cystatinpepstatin
inhibitor
capabl
inhibit
three
major
proteas
famili
member
found
lysosom
thu
use
cpi
measur
combin
effect
endosom
papainlik
cystein
proteas
inhibitor
plcp
aspartyl
proteas
inhibitor
asparagin
endopeptidas
inhibitor
aep
result
conclud
inhibit
broad
rang
endosom
proteas
effici
block
fusion
mhv
indic
effici
entri
requir
activ
lysosom
proteas
gener
class
fusion
protein
requir
cleavag
upstream
fp
render
fusion
compet
howev
protein
mhv
cleav
boundari
fig
proteas
cleavag
site
identifi
close
fusion
peptid
view
inhibit
mhv
entri
panlysosom
proteas
inhibitor
cpi
analog
class
fusion
protein
hypothes
addit
cleavag
protein
immedi
upstream
fp
necessari
induc
fusion
test
hypothesi
introduc
optim
furin
cleavag
site
fc
substitut
three
amino
acid
arg
immedi
upstream
highli
conserv
arg
indic
bold
occur
ntermin
fp
recombin
mhv
carri
fc
subunit
design
figur
western
blot
analysi
protein
purifi
stock
viru
use
antibodi
recogn
subunit
show
evid
cleavag
newli
introduc
fc
site
appar
cleavag
posit
occur
viru
product
figur
text
mhv
carri
wild
type
mutant
protein
display
similar
growth
kinet
figur
b
text
next
analyz
whether
introduc
fc
affect
sensit
recombin
mhv
cpi
exhibit
inhibitori
activ
toward
furin
thu
cell
pretreat
cpi
min
subsequ
infect
wild
type
mhveflm
mutant
contain
virus
express
luciferas
report
gene
presenc
proteas
inhibitor
hpi
cell
lyse
viralrepl
depend
luciferas
express
level
determin
introduct
fc
result
recombin
viru
longer
sensit
inhibit
lysosom
proteas
figur
probabl
protein
cleav
furin
endocyt
compart
confirm
longer
depend
cleavag
lysosom
proteas
studi
presum
depend
furin
cleavag
entri
analyz
abil
infect
haploid
cell
lack
thu
function
hop
complex
requir
late
endosometolysosom
matur
absenc
presenc
furin
inhibitor
fi
pretreat
mhv
receptorexpress
cell
furin
inhibitor
fi
mock
treatment
cell
inocul
mhveflm
mutant
viru
presenc
absenc
fi
hpi
cell
lyse
viralrepl
depend
luciferas
express
level
determin
agreement
previou
result
fig
infect
mhv
carri
wild
type
sever
reduc
cell
lack
function
hop
complex
addit
fi
alter
effect
figur
red
bar
contrast
infect
decreas
lack
function
hop
complex
howev
fi
treatment
clearli
neg
effect
viru
much
dramat
absenc
function
hop
complex
cell
figur
blue
conclus
lost
requir
function
hop
complex
parallel
viru
becom
insensit
panlysosom
proteas
inhibitor
cpi
contrast
viru
wild
type
mutant
viru
becam
sensit
inhibit
furin
cleavag
explor
entri
requir
assess
effect
rnaimedi
downregul
earli
late
endosom
hop
complex
associ
gene
therefor
cell
transfect
three
differ
sirna
per
gene
h
infect
wild
type
mhveflm
mutant
protein
contain
mhv
hpi
cell
lyse
viralrepl
depend
luciferas
express
level
determin
found
previous
fig
infect
wild
type
protein
carri
mhv
reduc
gene
silenc
figur
red
bar
hand
infect
significantli
diminish
downregul
earli
endosom
protein
late
endosom
protein
hop
complex
compon
figur
blue
bar
consist
infect
mhv
carri
wild
type
mutant
protein
equal
block
inhibitor
clathrinmedi
endocytosi
wherea
viru
mutant
much
less
sensit
inhibitor
endosom
matur
includ
perturb
actin
cytoskeleton
figur
text
result
conclud
introduct
fc
immedi
upstream
fp
abolish
requir
traffick
virion
lysosom
process
lysosom
proteas
result
viru
still
depend
clathrinmedi
endocytosi
requir
furin
cleavag
effici
entri
enzym
occur
earlier
endocyt
pathway
result
indic
proteas
cleavag
site
upstream
spike
protein
fp
import
determin
intracellular
site
fusion
gain
insight
put
proteas
cleavag
site
correspond
region
protein
cov
analyz
sequenc
region
sever
alpha
beta
gamma
coronavirus
perform
clustalw
sequenc
align
fusion
peptid
sequenc
found
highli
conserv
amongst
differ
coronavirus
also
arginin
residu
immedi
upstream
predict
fusion
peptid
highli
conserv
except
fipv
serotyp
ii
interestingli
merscov
ibvbeaudett
contain
minim
furin
cleavag
site
argxxarg
upstream
fusion
peptid
figur
analog
result
obtain
fcsmutant
mhv
predict
fipv
merscov
would
differ
proteas
inhibitor
sensit
lysosom
traffick
requir
corrobor
find
decid
analyz
entri
two
coronavirus
end
hela
cell
express
fipv
receptor
helafapn
cell
subject
sirnamedi
downregul
late
endosom
protein
hop
complex
subunit
follow
inocul
luciferas
express
fipv
infect
fipv
significantli
affect
sirnamedi
downregul
protein
requir
late
endosometolysosom
fusion
figur
sinc
requir
function
hop
complex
indic
fusion
lysosom
observ
mhv
analyz
whether
fipv
requir
process
lysosom
proteas
effici
entri
well
result
indic
inde
case
fipvdriven
luciferas
express
diminish
presenc
panlysosom
proteas
inhibitor
cpi
fig
hand
infect
fipv
affect
fi
merscov
carri
fc
protein
immedi
upstream
fp
hypothes
viru
requir
traffick
lysosom
process
lysosom
proteas
effici
entri
test
predict
cell
pretreat
fi
panlysosom
proteas
inhibitor
cpi
min
cell
subsequ
inocul
merscov
moi
presenc
inhibitor
hpi
cell
fix
number
infect
cell
determin
use
immunocytochemistri
widefield
microscopi
result
indic
contrast
wild
type
mhv
fipv
similarli
recombin
mhv
carri
fc
immedi
upstream
fp
infect
merscov
strongli
inhibit
fi
cpi
figur
indic
merscov
requir
traffick
lysosom
effici
entri
base
result
conclud
cleavag
site
cov
protein
immedi
upstream
fp
key
determin
intracellular
site
fusion
result
studi
provid
explan
sever
appar
conflict
result
earlier
studi
respect
process
mhv
cell
entri
particularli
also
regard
necess
proteolyt
cleavag
cov
protein
use
replicationindepend
fusion
assay
confirm
mhv
entri
requir
clathrinmedi
endocytosi
despit
wellknown
abil
mhv
protein
caus
cellcel
fusion
neutral
ph
demonstr
mhv
particl
traffic
fuse
lysosom
yet
mhv
much
less
sensit
perturb
low
ph
endolysosom
system
low
phdepend
control
virus
vsv
iav
result
addit
indic
fusion
occur
protein
mhv
requir
proteolyt
cleavag
immedi
upstream
fp
like
class
fusion
protein
effici
inhibit
mhv
entri
observ
use
panlysosom
proteas
inhibitor
could
achiev
use
specif
proteas
inhibitor
introduct
optim
furin
cleavag
site
protein
immedi
upstream
fp
abolish
requir
traffick
virion
lysosom
fusion
howev
viru
still
requir
clathrinmedi
uptak
effici
entri
consist
common
mechan
entri
cov
fipv
merscov
latter
contain
furin
cleavag
site
immedi
upstream
fp
shown
requir
traffick
lysosom
process
lysosom
proteas
effici
entri
base
result
propos
model
cleavag
site
immedi
upstream
fp
essenti
determin
intracellular
site
cov
fusion
figur
import
clathrinmedi
endocytosi
endosom
traffick
entri
mhv
reveal
sever
complementari
approach
one
sirnamedi
gene
silenc
although
except
knockdown
monitor
protein
level
believ
approach
firmli
demonstr
import
novel
host
factor
sever
reason
valid
sirna
use
experiment
condit
confirm
analyz
mrna
express
level
sever
gene
quantit
rtpcr
furthermor
made
use
three
independ
sirna
per
target
gene
target
classifi
hit
least
two
three
sirna
show
phenotyp
importantli
find
strengthen
target
multipl
protein
per
host
cell
pathwaycomplex
time
similar
result
moreov
hit
obtain
replicationdepend
report
assay
confirm
novel
replicationindepend
enzym
complement
entri
assay
also
use
recombin
virus
differ
spike
protein
enabl
us
show
inhibit
viru
infect
upon
sirna
transfect
result
differ
viru
entri
viru
replic
final
result
obtain
corrobor
use
larg
panel
inhibitor
make
use
haploid
knockout
cell
late
endosometolysosom
traffick
inhibit
result
demonstr
mhv
requir
endocyt
uptak
viru
entri
despit
protein
abil
induc
cellcel
fusion
neutral
ph
endocyt
uptak
also
requir
mutant
viru
carri
protein
fc
immedi
upstream
fp
despit
rel
insensit
high
concentr
therefor
abil
viru
infect
cell
presenc
necessarili
impli
viru
entri
occur
cell
surfac
also
recombin
mhv
carri
spike
protein
mhvjhm
found
enter
via
clathrinmedi
endocytosi
figur
text
despit
abil
caus
extens
cellcel
fusion
abil
mhv
caus
cellcel
fusion
neutral
ph
requir
endocyt
uptak
viruscel
fusion
suggest
differ
requir
trigger
two
fusion
process
similarli
rsv
recent
shown
enter
cell
endocyt
uptak
despit
abil
viru
caus
cellcel
fusion
present
studi
confirm
extend
previou
public
mhv
entri
via
clathrinmedi
endocytosi
sirna
downregul
clathrinmedi
endocytosisassoci
protein
clathrin
heavi
chain
cltc
dynamin
agent
affect
uptak
pathway
chlopro
dynasor
capabl
inhibit
infect
mhv
importantli
find
could
confirm
novel
replicationindepend
viruscel
fusion
assay
therebi
directli
show
involv
clathrinmedi
endocytosi
entri
mhv
analysi
sever
accessori
factor
clathrinmedi
endocytosi
show
clathrinmedi
entri
mhv
strain
depend
clathrinadaptor
previous
clathrinmedi
entri
mhv
strain
also
shown
independ
base
use
inhibitor
earlier
conclud
mhv
entri
depend
cholesterol
lipidraft
may
indic
caveolaemedi
endocytosi
although
replicationdepend
assay
indic
requir
caveolin
infect
protein
shown
involv
viru
entri
use
fusion
assay
also
deplet
protein
involv
caveolaemedi
endocytosi
includ
caveolin
flotillin
affect
mhv
infect
fusion
interestingli
fusion
mhv
sever
inhibit
eipa
inhibitor
nah
exchang
regard
hallmark
inhibitor
macropinocytosi
appar
inhibit
viru
entri
eipa
prove
viru
enter
via
particular
pathway
eipa
report
affect
sever
cellular
process
includ
actin
remodel
intern
lipid
raft
distribut
endosom
even
clathrinmedi
endocytosi
similar
result
obtain
hela
cell
also
infect
murin
cell
inhibit
compound
interf
clathrinmedi
endocytosi
figur
text
mhv
virion
requir
traffick
endocyt
pathway
lysosom
effici
entri
upon
clathrinmedi
uptak
virion
temporarili
associ
earli
endosom
demonstr
coloc
live
cell
imag
furthermor
import
earli
endosom
entri
indic
sirnamedi
downregul
variou
protein
associ
earli
endosom
inhibit
mhv
infect
well
viruscel
fusion
howev
mhv
particl
appear
fuse
earli
endosom
live
cell
imag
indic
fusion
larg
occur
late
endosom
andor
lysosom
consist
deplet
host
protein
associ
late
endosom
late
endosometolysosom
matur
hop
complex
subunit
addit
block
late
endosometolysosom
traffick
shown
inhibit
infect
viruscel
fusion
import
lysosom
entri
confirm
use
knockout
cell
lack
function
hop
complex
review
hop
complex
see
interestingli
cell
lysosom
cluster
perinuclear
region
cell
rather
dispers
throughout
cytoplasm
complement
miss
hop
subunit
restor
normal
lysosom
distribut
entri
mhv
figur
text
import
late
endosometolysosom
traffick
effici
entri
also
observ
murin
cell
figur
text
carri
protein
jhm
figur
text
corrobor
import
traffick
mhv
virion
endocyt
pathway
perturb
endosom
matur
addit
inhibitori
agent
ammonium
chlorid
chloroquin
monensin
inhibit
infect
fusion
mhv
also
import
actin
microtubul
cytoskeleton
demonstr
inhibit
mhv
entri
downregul
complex
factor
microtubuleassoci
transport
dynein
addit
actin
microtubuleaffect
drug
may
explain
document
involv
cytoskeleton
endosom
matur
review
inde
entri
presum
fuse
earli
endosom
much
less
affect
actinaffect
drug
mhv
carri
wild
type
spike
protein
figur
text
howev
exclud
actin
also
play
role
clathrinmedi
uptak
mhv
particl
observ
vsv
pathogen
depend
clathrinmedi
endocytosi
review
mhv
particl
requir
traffick
low
ph
environ
lysosom
achiev
membran
fusion
nevertheless
mhv
much
less
sensit
elev
ph
endolysosom
system
addit
virus
known
fuse
earli
late
endosom
vsv
iav
inhibitor
vacuolartyp
hatpas
effect
block
mhv
entri
high
concentr
known
prevent
endosom
matur
addit
elev
ph
absenc
function
hop
complex
requir
late
endosometolysosom
matur
affect
infect
cell
vsv
iav
entri
mhv
sever
reduc
thu
low
ph
trigger
mediat
entri
vsv
iav
endosom
system
cell
suffici
induc
fusion
mhv
environment
cue
present
lysosom
appar
requir
activ
conform
chang
protein
lead
fusion
inde
inhibit
three
major
class
proteas
present
lysosom
cpi
effect
prevent
mhv
fusion
infect
murin
cell
mhv
also
inhibit
cpi
figur
text
strikingli
inhibitor
affect
member
singl
proteas
famili
none
littl
impact
mhv
fusion
result
consist
function
redund
proteas
famili
member
may
explain
previou
studi
use
specif
lysosom
proteas
inhibitor
fail
detect
entri
inhibit
also
inhibit
mhv
entri
may
explain
known
abil
proteasom
inhibitor
neg
affect
lysosom
proteas
although
exclud
affect
entri
interfer
lysosom
traffick
result
indic
cleavag
protein
immedi
upstream
fp
essenti
cov
entri
determin
intracellular
site
fusion
although
demonstr
cleavag
mhv
fp
proxim
posit
directli
recent
studi
found
cleav
form
mhv
subunit
correspond
fusionact
form
furthermor
introduct
optim
fc
fp
proxim
posit
abolish
entri
inhibit
panlysosom
proteas
inhibitor
whilst
introduc
depend
furinrel
enzym
consist
known
presenc
activ
furin
earli
endosom
review
mutant
viru
longer
requir
traffick
late
endosomeslysosom
entri
occur
howev
presenc
furin
inhibitor
entri
mutant
mhv
much
effici
wild
type
cell
cell
lack
function
hop
complex
fig
indic
certain
circumst
lysosom
proteas
may
play
role
entri
viru
well
traffick
virion
lysosom
shown
also
import
entri
fipv
merscov
agreement
latter
viru
contain
put
fc
immedi
upstream
fp
correspondingli
entri
fipv
inhibit
panlysosom
proteas
inhibitor
cpi
furin
inhibitor
reciproc
held
true
merscov
import
protein
cleavag
downstream
boundari
upstream
fp
infect
far
demonstr
sarscov
ibv
base
present
studi
work
other
conclud
cleavag
fp
proxim
posit
like
gener
requir
cov
entri
except
possibl
ibv
cleavag
posit
appear
occur
virionproduc
cell
observ
releas
virion
target
cell
studi
suggest
receptor
bind
environment
cue
necessari
render
cleavag
site
access
proteolysi
intact
virion
also
sever
virus
includ
rsv
ebola
viru
cleavag
fusion
protein
upon
endocytosi
shown
requir
entri
result
furthermor
show
cleavag
fpproxim
posit
import
determin
intracellular
site
fusion
question
remain
howev
cov
evolv
fuse
earli
endosom
vesicl
other
requir
traffick
lysosom
view
grow
number
proteas
shown
cleav
cov
spike
protein
question
probabl
studi
relat
proteolyt
enzym
avail
cov
target
tissu
cell
vivo
murin
fibroblast
felin
fcwf
cell
atcc
use
propag
recombin
mhv
fipv
virus
respect
mdck
vero
cell
use
propag
pseudotyp
renilla
luciferas
express
influenza
pseudoviru
merscov
respect
describ
previous
cell
maintain
monolay
cultur
dulbecco
modifi
eagl
medium
dmem
lonza
supplement
fetal
bovin
serum
fb
helaatcc
cell
stabli
express
murin
cell
use
infect
experi
mhv
cell
stabli
express
defici
use
fusion
assay
stabl
cell
line
gener
use
moloney
murin
leukemia
mlv
retrovir
vector
mlv
produc
cell
tripl
plasmid
transfect
transfer
vector
contain
gene
well
puromycin
neomycin
resist
marker
gene
respect
combin
express
vector
encod
mlv
gagpol
vsv
spike
protein
g
upon
mlv
transduct
stabli
transduc
cell
select
puromycin
andor
mgml
sigma
mainten
puromycin
andor
mgml
dmem
supplement
fb
cell
knockout
deriv
thereof
describ
previous
cell
stabli
transfect
flagtag
use
mlv
transduct
describ
use
blasticidin
resist
marker
gene
transfer
vector
stabli
transduc
cell
select
maintain
blasticidin
cell
deriv
also
provid
describ
allow
infect
cell
mhv
mhv
fusion
inhibitor
peptid
describ
synthes
genscript
peptid
dilut
trishcl
mm
ph
egta
mm
stock
solut
use
final
concentr
fdg
anaspec
dissolv
dmso
result
mm
stock
solut
stock
mm
cycloheximid
chx
sigma
bafilomycin
enzo
life
scienc
mm
chloroquin
chloq
sigma
mm
dynasor
dyn
enzo
life
scienc
mm
dyngo
abcam
mm
ethylisopropyl
amilorid
eipa
enzo
life
scienc
mm
nocodazol
noc
sigma
mm
latrunculin
lata
enzo
life
scienc
mm
jasplakinolid
jasp
sigma
mm
cytochalasin
b
cytob
sigma
mm
cytochalasin
cytod
sigma
mm
sigma
mm
brefeldin
brefa
sigma
mm
furin
inhibitor
fi
calbiochem
prepar
dmso
dilut
experi
except
indic
otherwis
stock
ammonium
chlorid
fluka
mm
aebsf
mm
leupeptin
mm
camostat
mgml
aprotinin
obtain
sigma
prepar
use
final
concentr
mm
chlorpromazin
chlopro
sigma
mm
enzo
life
scienc
prepar
use
final
concentr
stock
mm
monensin
mon
sigma
mm
phosphoramidon
sigma
prepar
methanol
meoh
use
final
concentr
respect
mgml
cycloheximid
chx
sigma
mm
pepstatin
sigma
prepar
methanol
etoh
use
final
concentr
respect
solvent
etoh
meoh
dmso
obtain
sigmaaldrich
stock
cpi
pb
made
use
final
concentr
plasmid
construct
use
convent
clone
techniqu
gene
isol
e
coli
strain
dna
extract
pcr
gene
clone
pcagg
vector
transient
express
mlvbase
pqcxip
transfer
vector
clontech
result
gener
stabl
cell
line
gene
encod
mhv
receptor
clone
pqcxin
result
rna
transcript
vector
use
gener
recombin
mhv
use
target
recombin
gener
use
deriv
contain
gfp
express
cassett
e
gene
gener
describ
previous
firefli
luciferas
transcript
vector
use
gener
gener
sitedirect
mutagenesi
therebi
chang
sequenc
encod
airgr
immedi
upstream
fp
rrrrrencod
sequenc
vector
pxherlm
transcript
vector
use
gener
express
firefli
luciferas
gener
introduc
firefli
luciferas
express
cassett
e
gene
similarli
describ
previous
transcript
vector
contain
gene
encod
protein
mhvjhm
latter
vector
kindli
provid
susan
weiss
recombin
mhvegfpm
viru
contain
gfp
express
cassett
e
gene
contain
renilla
luciferas
express
cassett
e
gene
fc
fpproxim
posit
contain
spike
gene
jhm
luciferas
express
cassett
gener
target
rna
recombin
describ
briefli
donor
rna
gener
linear
transfer
vector
describ
electropor
fcwf
cell
infect
interspeci
chimer
fmhv
coronaviru
deriv
ectodomain
spike
protein
replac
felin
coronaviru
therebi
chang
host
cell
tropism
electropor
fcwf
cell
seed
onto
monolay
cell
h
incub
cultur
supernat
contain
progeni
virus
harvest
genotyp
recombin
virus
confirm
two
round
plaqu
purif
passag
stock
use
experi
gener
mhveflm
mhverlm
contain
firefli
renilla
luciferas
express
cassett
e
gene
contain
n
protein
tag
describ
construct
fipv
express
renilla
luciferas
report
previous
recombin
pseudoviru
gener
describ
construct
iavwsn
pseudoviru
express
renilla
luciferas
also
describ
previous
virus
store
cultur
medium
supplement
mm
hepe
upon
sucros
cushion
purif
tn
buffer
mm
triscl
ph
mm
nacl
cell
seed
one
day
prior
transfect
dish
use
oligofectamin
life
technolog
reagent
three
independ
nonoverlap
sirna
predesign
silenc
select
sirna
ambion
per
gene
individu
transfect
target
cell
accord
manufactur
instruct
transfect
mix
one
well
contain
sirna
oligofectamin
optimem
gibco
transfect
done
final
volum
optimem
hour
post
transfect
dmem
fb
ad
cell
infect
hour
post
transfect
cell
subject
sirnamedi
gene
knockdown
describ
hpi
cell
harvest
trypsin
singlecel
suspens
count
collect
centrifug
cellular
rna
extract
use
rneasi
mini
kit
qiagen
mrna
level
gene
analyz
qrtpcr
use
custom
design
pair
specif
primer
gene
result
bp
product
rna
level
measur
use
gotaq
rtqpcr
system
promega
accord
manufactur
instruct
lightcycl
roch
express
level
correct
cell
number
viabil
determin
assay
roch
cell
inocul
mhvegfpm
moi
infect
cell
dmem
fb
h
inoculum
replac
warm
dmem
fb
hpi
cell
infect
mhvegfpm
trypsin
fix
formaldehyd
solut
pb
cell
wash
taken
fac
buffer
fb
edta
pb
gfp
express
quantifi
fac
analysi
fac
calibur
benson
dickson
use
flowjo
softwar
sampl
least
cell
analyz
hela
cell
inocul
luciferas
express
pseudo
virus
mhveflm
iavrluc
fipvrluc
jhm
moi
unless
indic
otherwis
dmem
imdm
supplement
fb
hpi
inoculum
replac
warm
cultur
medium
contain
fb
cell
lyse
hpi
mhv
vsv
fipv
hpi
iav
passiv
lysi
buffer
promega
firefli
luciferas
express
assess
use
firefli
luciferas
assay
system
promega
use
homemad
system
mm
tricin
edta
mm
mm
dtt
mm
atp
dluciferin
renilla
luciferas
express
assess
use
renilla
luciferas
assay
system
promega
light
emiss
measur
centro
lb
luminomet
indic
cell
transfect
sirna
prior
inocul
describ
luciferas
express
level
rel
light
unit
rlu
correct
cell
number
viabil
determin
assay
roch
indic
cell
treat
pharmacolog
inhibitor
start
min
prior
h
post
inocul
cell
inocul
merscov
moi
fbscontain
dmem
h
post
infect
cell
fix
formaldehyd
pb
cell
stain
use
rabbit
antisarscov
antibodi
crossreact
merscov
accord
standard
protocol
use
fitcconjug
swineantirabbit
antibodi
number
infect
cell
determin
cell
count
widefield
fluoresc
microscop
complement
fusion
assay
perform
describ
previous
briefli
cell
preload
fdg
substrat
incub
adher
target
cell
fb
mm
fdg
pb
room
temperatur
min
incub
excess
fb
pb
ad
supernat
remov
replac
growth
medium
recoveri
period
min
cell
mock
treat
differ
inhibitor
min
viru
bound
cell
dmem
fc
absenc
presenc
inhibitor
moi
min
synchron
infect
cell
shift
h
cell
trypsin
transfer
eppendorf
tube
wash
immedi
analyz
fac
experi
proteas
inhibitor
cell
load
fdg
hypoton
shock
trypsin
collect
cell
case
fdg
load
cell
incub
ice
h
analyz
fac
mhv
wt
viru
grown
cell
purifi
sucros
cushion
tn
buffer
centrifug
rcf
h
supernat
remov
pellet
resuspend
tn
buffer
overnight
ice
concentr
viru
solut
subject
purif
pfefferkorn
gradient
cushion
spin
h
rcf
clear
viru
band
visibl
viru
band
collect
dilut
tn
buffer
viru
pellet
centrifug
rcf
h
resuspend
sodium
phosphat
nacl
buffer
ph
overnight
ice
purifi
viru
solut
label
use
dylight
nh
thermo
scientif
accord
manufactur
instruct
infect
label
viru
confirm
analysi
qrtpcr
cell
seed
glassbottom
chamber
reach
confluenc
next
day
plasmid
encod
mrfptag
transfect
cell
one
day
seed
use
lipofectamin
life
technolog
accord
manufactur
instruct
h
transfect
bound
cell
ice
moi
h
dmem
fb
inoculum
remov
cell
wash
cold
pb
remov
unbound
viru
warm
imag
medium
dmem
without
phenol
red
fc
contain
trypan
blue
invitrogen
ad
cell
chamber
cell
membran
imperm
trypan
blue
shift
express
spectrum
cell
surfac
bound
particl
render
undetect
nm
channel
describ
differ
low
medium
rfp
express
cell
imag
live
min
time
frame
min
post
warm
min
interv
therebi
acquir
zstack
imag
slice
thick
averag
slice
per
stack
record
zeiss
axio
observ
invers
spinningdisk
confoc
microscop
equip
full
box
stage
incub
includ
pecon
argonkrypton
heliumneon
laser
two
photometr
evolv
backillumin
electronmultipli
chargecoupleddevic
emccd
camera
oil
alpha
plan
apochromat
object
use
fluoresc
imag
export
asczi
file
zeiss
subsequ
import
fiji
imagej
nih
upon
import
fiji
color
channel
split
save
tag
imag
file
format
viru
movement
manual
track
xy
z
direct
green
channel
use
mtrackj
plugin
track
save
subsequ
load
onto
red
channel
viru
spot
area
underli
circl
measur
gray
mean
valu
virus
consid
coloc
gray
mean
valu
reach
maximum
subsequ
red
blue
color
channel
merg
track
import
virus
classifi
use
viral
track
viru
coloc
endosom
vesicl
least
four
sequenti
frame
viru
categor
associ
virus
initi
coloc
separ
vesicl
classifi
associatingdissoci
viru
particl
fade
disappear
could
found
zstack
whilst
coloc
previou
interv
endosom
vesicl
categor
fuse
figur
text
viral
particl
coloc
endosom
compart
neither
dissoci
fade
min
acquisit
period
classifi
nonfus
quantif
method
analyz
cell
virion
total
cell
virion
total
cell
virion
total
acquir
three
independ
experi
sequenc
base
sequenc
result
sequenc
bcov
gi
fipv
gi
gi
gi
sarscov
gi
merscov
gi
gi
gi
ibvbeaudett
gi
obtain
ncbi
align
perform
entir
length
spike
protein
use
megalign
lasergen
dnastar
use
clustalw
align
gap
penalti
gap
length
penalti
delay
diverg
sequenc
dna
translat
weight
protein
weight
matrix
pam
seri
dna
weight
matrix
clustalw
hela
cell
cotransfect
mrfptag
similarli
describ
previous
briefli
hela
cell
seed
one
day
prior
transfect
plate
use
oligofectamin
life
technolog
reagent
three
independ
nonoverlap
sirna
predesign
silenc
select
sirna
ambion
per
gene
individu
transfect
target
cell
plasmid
transfect
mix
one
well
contain
sirna
ng
plasmid
oligofectamin
optimem
gibco
transfect
done
final
volum
optimem
hour
post
transfect
dmem
fb
ad
rfp
express
analyz
h
post
transfect
use
evo
cell
imag
system
confluent
cell
stabli
express
counterpart
detach
use
cell
scraper
homogen
fix
min
incub
block
buffer
bsa
sigma
pb
h
cell
incub
nceacamfc
antibodi
wash
stain
goatantirabbit
antibodi
life
technolog
wash
cell
analyz
fac
gate
singl
cell
per
sampl
cell
trypsin
collect
centrifug
rcf
min
pellet
resuspend
laemmli
sampl
buffer
contain
mm
dtt
boil
min
subject
electrophoresi
acrylamid
biorad
gel
virus
purifi
concentr
sucros
cushion
tn
buffer
rcf
pellet
viru
resuspend
tn
buffer
overnight
ice
addit
laemmli
sampl
buffer
final
concentr
mm
dtt
sampl
boil
min
subject
electrophoresi
acrylamid
biorad
gel
upon
transfer
nitrocellulos
membran
millipor
presenc
cellular
viral
protein
probe
antibodi
rabbit
pab
abcam
flag
hrplabel
mous
antiflag
mab
sigma
subunit
mhv
mous
mab
dilut
necessari
blot
subsequ
incub
hrplabel
rabbit
antimous
swine
antirabbit
antibodi
dilut
dako
bind
hrplabel
antibodi
visual
use
amersham
ecl
western
blot
substrat
ge
healthcar
life
scienc
accord
manufactur
instruct
imag
local
cell
cell
seed
onto
coverslip
one
day
prior
stain
cell
fix
formaldehyd
pb
min
rt
wash
pb
subsequ
permeabil
pb
contain
min
cell
incub
antibodi
rabbit
pab
dilut
abcam
bsa
pb
follow
incub
secondari
antibodi
coupl
phalloidin
dapi
life
technolog
sampl
analyz
use
confoc
laserscan
microscop
leica
speii
cell
infect
moi
moi
mhverlm
dmem
contain
fb
mm
hepe
infect
medium
h
infect
supernat
replac
fresh
infect
medium
infect
allow
progress
period
h
everi
h
small
sampl
cultur
supernat
collect
immedi
frozen
sampl
subsequ
analyz
assay
cell
subject
qrtpcr
analysi
quantifi
virion
product
therefor
viral
rna
extract
sampl
use
qiaamp
viral
rna
mini
kit
qiagen
rel
amount
viral
rna
present
determin
lightcycl
use
lightcycl
rna
master
hydrolysi
kit
roch
appli
bioscienc
specif
primer
probe
target
mhv
gene
comparison
standard
curv
gene
swissprot
id
cltc
nsf
vcl
